<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: A new classification of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> (CKD) was proposed by the <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">Kidney Disease</z:e>: Improving Global Outcomes (KDIGO) in 2011 </plain></SENT>
<SENT sid="1" pm="."><plain>The major point of revision of this classification was the introduction of a two-dimensional staging of the CKD according to the level of <z:mp ids='MP_0002871'>albuminuria</z:mp> in addition to the GFR level </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, the previous CKD stage 3 was subdivided into two stages (G3a and G3b) </plain></SENT>
<SENT sid="3" pm="."><plain>We examined the prevalence of diabetic micro- and <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathies</z:e> in patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> based on the new classification </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: A cross-sectional study was performed in 2018 patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> of the diabetic micro- and <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathies</z:e> significantly more common in the later stages of both the GFR and <z:mp ids='MP_0002871'>albuminuria</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>The proportion of subjects with diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e>, cerebrovascular disease and <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> was significantly higher in the G3b group than in the G3a group </plain></SENT>
<SENT sid="7" pm="."><plain>The brachial-ankle pulse wave velocity, which is one of the surrogate markers for <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, was also significantly greater in the G3b group compared to the G3a group </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: The subdivision of the G3 stage in the revised classification proposed by the KDIGO is useful to evaluate the risk for <z:e sem="disease" ids="C0011875" disease_type="Disease or Syndrome" abbrv="">diabetic vascular complications</z:e> </plain></SENT>
</text></document>